BRAFV600E negatively regulates the AKT pathway in melanoma cell lines.
Cross-feedback activation of MAPK and AKT pathways is implicated as a resistance mechanism for cancer therapeutic agents targeting either RAF/MEK or PI3K/AKT/mTOR. It is thus important to have a better understanding of the molecular resistance mechanisms to improve patient survival benefit from thes...
Enregistré dans:
Auteurs principaux: | , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f977105d31fa4f8f9f44e379c7007545 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|